Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: A cohort study

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Pembrey, Lucy ^a   Raynor, Pauline ^b   Griffiths, Paul ^c   Chaytor, Shelley ^d   Wright, John ^b   Hall, Andrew J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b BRADFORD INSTITUTE FOR HEALTH RESEARCH   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; COHORT STUDIES; CYTOMEGALOVIRUS; ETHNIC GROUPS; FEMALE; GREAT BRITAIN; HERPESVIRUS 3, HUMAN; HERPESVIRUS 4, HUMAN; HUMANS; LONGITUDINAL STUDIES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84894229568     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081881     Document Type: Article

References (35)

1. Townsend CL, Peckham CS, Tookey PA (2011) Surveillance of congenital cytomegalovirus in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed 96: F398-F403. doi:10.1136/adc.2010.199901. PubMed: 21289013.
2. Griffiths PD, McLean A, Emery VC (2001) Encouraging prospects for immunisation against primary cytomegalovirus infection. Vaccine 19: 1356-1362. doi:10.1016/S0264-410X(00)00377-7. PubMed: 11163656.
3. Wang C, Zhang X, Bialek S, Cannon MJ (2011) Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis 52: e11-e13. doi:10.1093/cid/ciq085. PubMed: 21288834.
4. Stronati M, Lombardi G, Di Comite A, Fanos V (2007) Breastfeeding and cytomegalovirus infections. J Chemother 19 Suppl 2: 49-51. PubMed: 18073182.
5. Cannon MJ, Hyde TB, Schmid DS (2011) Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol 21: 240-255. doi:10.1002/rmv.695. PubMed: 21674676.
6. Balfour HH Jr, Odumade OA, Schmeling DO, Mullan BD, Ed JA, et al. (2013) Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis 207: 80-88. doi:10.1093/infdis/jis646. PubMed: 23100562. Available online at: doi:10.1093/infdis/jis646 Available online at: PubMed: 23100562
7. Daley AJ, Thorpe S, Garland SM (2008) Varicella and the pregnant woman: prevention and management. Aust N Z J Obstet Gynaecol 48: 26-33. doi:10.1111/j.1479-828X.2007.00797.x. PubMed: 18275568.
8. Mandelbrot L (2012) Fetal varicella - diagnosis, management, and outcome. Prenat Diagn 32: 511-518. doi:10.1002/pd.3843. PubMed: 22514124.
9. Steininger C (2012) Cytomegalovirus vaccine: light on the horizon. Lancet Infect Dis 12: 257-259. doi:10.1016/S1473-3099(11)70367-X. PubMed: 22237176.
10. Griffiths PD (2012) Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation. Lancet Infect Dis 12: 790-798. doi:10.1016/S1473-3099(12)70197-4. PubMed: 23017365.
11. Long HM, Taylor GS, Rickinson AB (2011) Immune defence against EBV and EBV-associated disease. Curr Opin Immunol 23: 258-264. doi:10.1016/j.coi.2010. 12.014. PubMed: 21269819.
12. Ruiss R, Jochum S, Wanner G, Reisbach G, Hammerschmidt W et al. (2011) A virus-like particle-based Epstein-Barr virus vaccine. J Virol 85: 13105-13113. doi:10.1128/JVI.05598-11. PubMed: 21994444.
13. Cannon MJ, Schmid DS, Hyde TB (2010) Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20: 202-213. doi:10.1002/rmv.655. PubMed: 20564615.
14. Tookey PA, Ades AE, Peckham CS (1992) Cytomegalovirus prevalence in pregnant women: the influence of parity. Arch Dis Child 67: 779-783. doi:10.1136/adc.67.7-Spec-No.779. PubMed: 1325757.
15. Gaytant MA, Galama JM, Semmekrot BA, Melchers WJ, Sporken JM et al. (2005) The incidence of congenital cytomegalovirus infections in The Netherlands. J Med Virol 76: 71-75. doi:10.1002/jmv.20325. PubMed: 15778958.
16. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF et al. (2006) Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 43: 1143-1151. doi:10.1086/508173. PubMed: 17029132.
17. Higgins CD, Swerdlow AJ, Macsween KF, Harrison N, Williams H et al. (2007) A study of risk factors for acquisition of Epstein-Barr virus and its subtypes. J Infect Dis 195: 474-482. doi:10.1086/510854. PubMed: 17230406.
18. Morris MC, Edmunds WJ, Hesketh LM, Vyse AJ, Miller E et al. (2002) Sero-epidemiological patterns of Epstein-Barr and herpes simplex (HSV-1 and HSV-2) viruses in England and Wales. J Med Virol 67: 522-527. doi:10.1002/jmv.10132. PubMed: 12115998.
19. Talukder YS, Kafatos G, Pinot de Moira A, Aquilina J, Parker SP et al. (2007) The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK. Epidemiol Infect 135: 1344-1353. PubMed: 17445317.
20. Wright J, Small N, Raynor P, Tuffnell D, Bhopal R et al. (2013) Cohort Profile: The Born in Bradford multi-ethnic family cohort study. Int J Epidemiol 42: 978-991. doi:10.1093/ije/dys112. PubMed: 23064411.
21. Raynor P, Born in Bradford Collaborative G (2008) Born in Bradford, a cohort study of babies born in Bradford, and their parents: protocol for the recruitment phase. BMC Public Health 8: 327
22. Traviss GD, West RM, House AO (2012) Maternal mental health and its association with infant growth at 6 months in ethnic groups: results from the Born-in-Bradford birth cohort study. PLOS ONE 7: e30707. doi: 10.1371/journal.pone.0030707. PubMed: 22348019.
23. Barros AJ, Hirakata VN (2003) Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 3: 21. doi: 10.1186/1471-2288-3-21. PubMed: 14567763.
24. Bhopal R (2004) Glossary of terms relating to ethnicity and race: for reflection and debate. J Epidemiol Community Health 58: 441-445. doi: 10.1136/jech.2003.013466. PubMed: 15143107.
25. Gratacap-Cavallier B, Bosson JL, Morand P, Dutertre N, Chanzy B et al. (1998) Cytomegalovirus seroprevalence in French pregnant women: parity and place of birth as major predictive factors. Eur J Epidemiol 14: 147-152. doi:10.1023/A:1007450729633. PubMed: 9556173.
26. Santorelli G, Petherick E, Waiblinger D, Cabieses B, Fairley L (2013) Ethnic differences in the initiation and duration of breast feeding - results from the born in Bradford Birth Cohort Study. Paediatr Perinat Epidemiol 27: 388-392. doi:10.1111/ppe.12052. PubMed: 23772941.
27. Nichols RA, Averbeck KT, Poulsen AG, al Bassam MM, Cabral F et al. (2011) Household size is critical to varicella-zoster virus transmission in the tropics despite lower viral infectivity. Epidemics 3: 12-18. doi: 10.1016/j.epidem.2010.11.003. PubMed: 21420656.
28. Lolekha S, Tanthiphabha W, Sornchai P, Kosuwan P, Sutra S et al. (2001) Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am J Trop Med Hyg 64: 131-136. PubMed: 11442207.
29. Yamamoto AY, Mussi-Pinhata MM, Boppana SB, Novak Z, Wagatsuma VM et al. (2010) Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am J Obstet Gynecol 202: 297: e291-e298.
30. Townsend CL, Forsgren M, Ahlfors K, Ivarsson SA, Tookey PA et al. (2013) Long-term Outcomes of Congenital Cytomegalovirus Infection in Sweden and the United Kingdom. Clin Infect Dis 56: 1232-1239. doi: 10.1093/cid/cit018. PubMed: 23334811.
31. Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A et al. (2011) Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLOS ONE 6: e16103. doi:10.1371/journal.pone.0016103. PubMed: 21379581.
32. Pawelec G, McElhaney JE, Aiello AE, Derhovanessian E (2012) The impact of CMV infection on survival in older humans. Curr Opin Immunol 24: 507-511. doi:10.1016/j.coi.2012.04.002. PubMed: 22541724.
33. Griffiths PD, Stanton A, McCarrell E, Smith C, Osman M et al. (2011) Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet 377: 1256-1263. doi:10.1016/S0140-6736(11)60136-0. PubMed: 21481708.
34. Sabbaj S, Pass RF, Goepfert PA, Pichon S (2011) Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women. J Infect Dis 203: 1534-1541. doi:10.1093/infdis/ jir138. PubMed: 21592981.
35. Kharfan-Dabaja MA, Boeckh M, Wilck MB, Langston AA, Chu AH et al. (2012) A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis 12: 290-299. doi: 10.1016/S1473-3099(11)70344-9. PubMed: 22237175.